You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High grade bladder cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

Recruiting
  • Bladder Cancer
  • Pseudomonas aeruginosa
  • Jinan, Shandong, China
    Qilu hospital
Jul 26, 2023

Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • Chengdu, Sichuan, China
    West China Hospital
Aug 10, 2023

High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

Not yet recruiting
  • High Grade Serous Adenocarcinoma of Ovary
  • +3 more
  • (no location specified)
Oct 13, 2023

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in United States (UGN-102)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Homewood, Alabama
  • +4 more
Dec 15, 2022

High Grade Serous Ovarian Cancer (HGSOC) Trial (FAPI PET CT)

Not yet recruiting
  • High Grade Serous Ovarian Cancer (HGSOC)
  • FAPI PET CT
  • (no location specified)
Jul 20, 2023

Bladder Cancer Trial in Houston (Bladder tumor biopsy)

Recruiting
  • Bladder Cancer
  • Bladder tumor biopsy
  • Houston, Texas
    Baylor College of Medicine
Jan 14, 2022

Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • +2 more
  • PDD-TURBT with hexaminolevulinate (Hexvix®)
  • Power Led Saphira (TM) from KARL STORZ
  • (no location specified)
Jul 24, 2023

Non-muscle-invasive Bladder Cancer Trial in Xi'an (Standard infusion chemo, BL - 5 ala PDT)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • Standard infusion chemotherapy
  • BL - 5 ala PDT
  • Xi'an, Shaanxi, China
    Dalin He
Sep 19, 2022

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting
  • Ovarian Cancer
  • +6 more
  • (no location specified)
Oct 27, 2022

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

Enrolling by invitation
  • Ovarian Cancer
  • +2 more
  • CRS scoring
  • Routine blood laboratory testing before treatment
  • Guangzhou, Guangdong, China
    The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 2, 2023

Bladder Cancer Trial in Columbus (Specimen Ultra-High field MRI, chemo, Cystectomy and Lymphadenectomy)

Active, not recruiting
  • Bladder Cancer
  • Specimen Ultra-High field MRI
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Nov 9, 2022

Recurrent High Grade Uterine Cancer Trial in United States (Paclitaxel, Batiraxcept)

Not yet recruiting
  • Recurrent High Grade Uterine Cancer
  • San Francisco, California
  • +3 more
Apr 11, 2023

Bladder Cancer, Squamous Cell Carcinoma of the Bladder, Stage III Bladder Cancer Trial in Atlanta (3D conformal radiation

Terminated
  • Bladder Cancer
  • +4 more
  • 3D conformal radiation therapy
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 14, 2022

Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

Active, not recruiting
  • Non-muscle-invasive Bladder Cancer
  • Gemcitabine 1000 mg, Docetaxel 37.5g
  • Zagreb, Croatia
    University Hospital Centre Zagreb
Jan 20, 2023

Endometrial Cancer, Serous Adenocarcinoma, Uterine Tumor Trial (Niraparib oral capsule)

Not yet recruiting
  • Endometrial Cancer
  • +2 more
  • Niraparib oral capsule
  • (no location specified)
Oct 31, 2022

Recurrent Bladder Carcinoma, Stage 0a Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma Trial in Chicago (BCG

Active, not recruiting
Has Results
  • Recurrent Bladder Carcinoma
  • +3 more
  • BCG Solution
  • +3 more
  • Chicago, Illinois
    Northwestern University
Sep 27, 2022

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102)

Recruiting
  • Bladder Cancer
  • +2 more
  • Tucson, Arizona
  • +76 more
Jul 13, 2022

High Grade Glioma Trial in Cleveland (procedure, radiation, drug)

Recruiting
  • High Grade Glioma
  • LITT
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jan 5, 2023

High-Grade Ovarian Cancer Terms of Homologous Recombination

Not yet recruiting
  • Ovarian Cancer
  • +2 more
  • Standard of care
  • (no location specified)
Oct 7, 2022

Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

Recruiting
  • Non-muscle-invasive Bladder Cancer
  • Cairo, Egypt
    Mohamed Fawzy Salman
Nov 19, 2022

Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

Not yet recruiting
  • Lymphoma, B-Cell
  • +6 more
  • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
  • Guayaquil, Guayas, Ecuador
    Instituto Oncológico Nacional Dr. Juan Tanca Marengo
Apr 27, 2023

High Grade Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Peritoneal High Grade Serous

Recruiting
  • High Grade Fallopian Tube Serous Adenocarcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

High Grade Glioma, Glioblastoma Trial in Cleveland (Standard Surgical Treatment, Intraoperative Electrocorticography)

Not yet recruiting
  • High Grade Glioma
  • Glioblastoma
  • Standard Surgical Treatment
  • Intraoperative Electrocorticography
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Sep 30, 2022

Bladder Cancer Trial in Athens (Durvalumab)

Active, not recruiting
  • Bladder Cancer
  • Durvalumab
  • Athens, Attica, Greece
    Hellenic GenitoUrinary Cancer Group
Mar 22, 2022